Published in Neth J Med on June 01, 1994
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. J Clin Oncol (2008) 3.85
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer (2008) 2.11
Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians. Therap Adv Gastroenterol (2013) 0.80
Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011. Curr Oncol (2012) 0.75
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia. Lancet (1989) 3.03
Glutamine and the preservation of gut integrity. Lancet (1993) 2.72
Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr (1998) 2.35
Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg (2010) 2.30
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem (1999) 2.15
Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology (1997) 2.04
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative. Ital J Gastroenterol Hepatol (1999) 2.02
Helicobacter pylori and gastric carcinoma. Histopathology (1990) 1.98
Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut (2001) 1.86
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut (1994) 1.82
Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol (1998) 1.80
Antibody phage display technology and its applications. Immunotechnology (1998) 1.79
A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer (1988) 1.72
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Eur J Clin Invest (2001) 1.69
Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol (1993) 1.66
Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: association with relevant endoscopic disease. Gastrointest Endosc (1995) 1.66
EB/RP gene family encodes tubulin binding proteins. Int J Cancer (1999) 1.63
Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group. Eur J Gastroenterol Hepatol (1996) 1.54
Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery. Aliment Pharmacol Ther (2007) 1.53
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur J Gastroenterol Hepatol (1999) 1.45
The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain. Eur J Pediatr (1992) 1.44
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther (2011) 1.42
Tenascin and fibronectin expression in healing human myocardial scars. J Pathol (1996) 1.40
[Three patients with autoimmune hepatitis: the importance of early diagnosis and remission]. Ned Tijdschr Geneeskd (2005) 1.37
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol (2009) 1.36
A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett (1999) 1.30
Efforts to improve interobserver agreement in histopathological grading. J Clin Epidemiol (1995) 1.30
Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol (1996) 1.29
Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology (2000) 1.27
Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer (1988) 1.26
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum (1988) 1.24
Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol (2001) 1.24
No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg (1988) 1.23
MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer (1998) 1.21
Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis (2010) 1.21
Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma (1983) 1.18
Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol (1990) 1.18
Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther (2004) 1.18
Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut (2005) 1.17
Rapid staining of Campylobacter pyloridis. Histopathology (1987) 1.17
Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol (2000) 1.16
Gastroscopic screening in 80 patients with pernicious anaemia. Gut (1983) 1.15
The prevalence of anti-Helicobacter (Campylobacter) pylori antibodies in patients and healthy blood donors. J Med Microbiol (1990) 1.14
Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther (2001) 1.14
Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer (1994) 1.13
Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease. Aliment Pharmacol Ther (2002) 1.12
Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library. Eur J Biochem (1999) 1.11
Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics. Digestion (1990) 1.11
Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis (1998) 1.08
A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int J Cancer (1996) 1.06
Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res (1994) 1.06
Abnormal small bowel permeability and duodenitis in recurrent abdominal pain. Arch Dis Child (1990) 1.05
Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer (1993) 1.05
L-CAM expression in normal, premalignant, and malignant colon mucosa. J Pathol (1992) 1.04
Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology (1992) 1.03
Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion (1997) 1.03
Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res (1987) 1.03
Role of alimentation in irritable bowel syndrome. Digestion (2003) 1.02
Bacteria in the aetio-pathogenesis of gastric cancer: a review. Scand J Gastroenterol Suppl (1995) 1.02
Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut (1990) 1.02
High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting. Br J Cancer (1998) 1.02
Gastroesophageal reflux in children with recurrent abdominal pain. Acta Paediatr (1992) 1.02
Campylobacter associated gastritis in patients with non-ulcer dyspepsia. J Clin Pathol (1988) 1.01
Number and proliferation of neuroendocrine cells in normal human airway epithelium. Am J Respir Crit Care Med (1996) 1.01
Irritable bowel syndrome in general practice: an overview. Scand J Gastroenterol Suppl (2004) 1.01
Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol (1999) 1.01
Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology (1991) 1.01
Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. Mayo Clin Proc (1993) 0.99
High incidence of inflammatory bowel disease in The Netherlands: results of a prospective study. The South Limburg IBD Study Group. Dis Colon Rectum (1998) 0.99
Gut permeability, intestinal morphology, and nutritional depletion. Nutrition (1998) 0.99
Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective. J Clin Virol (2013) 0.99
Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol (2000) 0.98
Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Aliment Pharmacol Ther (1999) 0.98
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. Neth J Med (2007) 0.98
AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol (1998) 0.97
Epithelial-stromal interactions in colon cancer. Int J Dev Biol (1993) 0.97
Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment. Neth J Med (2002) 0.97
Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. J Immunol Methods (1999) 0.97
Pericarditis after therapy with interferon-alpha for chronic hepatitis C. Clin Rheumatol (1999) 0.97
Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Dermatol Surg (1997) 0.96
Fine needle aspiration cytology of inflammatory pseudotumor of the lung (plasma cell granuloma). Report of four cases. Acta Cytol (1990) 0.96
Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr (2000) 0.96
Cow's milk protein allergy and gastro-oesophageal reflux. Eur J Pediatr (1985) 0.95
Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy. J Clin Pathol (1988) 0.95
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol (1996) 0.95
An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line. Br J Cancer (1999) 0.95
Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas. J Pathol (1997) 0.94